Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Guizhou Provincial Institute of Chinese Materia Medica is a prominent research and development institution dedicated to the modernization of Traditional Chinese Medicine (TCM) and regional ethnomedicines. Established in 1956, the institute specializes in the entire lifecycle of herbal drug development, from the cultivation and standardization of medicinal plants to pharmacological screening and clinical application. It serves as a key technical hub for the pharmaceutical industry in Guizhou, focusing on high-value species like Gastrodia elata and Eucommia ulmoides. The institute's work encompasses resource conservation, quality standard setting, and the development of new botanical drug candidates. By integrating traditional knowledge with modern scientific methodologies, it facilitates the commercialization of innovative herbal products for various therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guizhou Provincial Institute of Chinese Materia Medica.